Cargando…

Rethinking methods used to evaluate effectiveness of therapeutics for COVID-19 and other viral respiratory illnesses

Detalles Bibliográficos
Autor principal: Rossignol, Jean-François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8756609/
https://www.ncbi.nlm.nih.gov/pubmed/35058984
http://dx.doi.org/10.2217/fvl-2021-0209
_version_ 1784632594949734400
author Rossignol, Jean-François
author_facet Rossignol, Jean-François
author_sort Rossignol, Jean-François
collection PubMed
description
format Online
Article
Text
id pubmed-8756609
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Future Medicine Ltd
record_format MEDLINE/PubMed
spelling pubmed-87566092022-01-18 Rethinking methods used to evaluate effectiveness of therapeutics for COVID-19 and other viral respiratory illnesses Rossignol, Jean-François Future Virol Editorial Future Medicine Ltd 2022-01-12 2021-11 /pmc/articles/PMC8756609/ /pubmed/35058984 http://dx.doi.org/10.2217/fvl-2021-0209 Text en © 2022 Future Medicine Ltd https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/)
spellingShingle Editorial
Rossignol, Jean-François
Rethinking methods used to evaluate effectiveness of therapeutics for COVID-19 and other viral respiratory illnesses
title Rethinking methods used to evaluate effectiveness of therapeutics for COVID-19 and other viral respiratory illnesses
title_full Rethinking methods used to evaluate effectiveness of therapeutics for COVID-19 and other viral respiratory illnesses
title_fullStr Rethinking methods used to evaluate effectiveness of therapeutics for COVID-19 and other viral respiratory illnesses
title_full_unstemmed Rethinking methods used to evaluate effectiveness of therapeutics for COVID-19 and other viral respiratory illnesses
title_short Rethinking methods used to evaluate effectiveness of therapeutics for COVID-19 and other viral respiratory illnesses
title_sort rethinking methods used to evaluate effectiveness of therapeutics for covid-19 and other viral respiratory illnesses
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8756609/
https://www.ncbi.nlm.nih.gov/pubmed/35058984
http://dx.doi.org/10.2217/fvl-2021-0209
work_keys_str_mv AT rossignoljeanfrancois rethinkingmethodsusedtoevaluateeffectivenessoftherapeuticsforcovid19andotherviralrespiratoryillnesses